21 October 2025
Latham & Watkins Advises Nalu Medical, Inc. on Acquisition by Boston Scientific
Advising firms
Deal team
29 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Hans Brigham Lead | Latham & Watkins LLP | Partner | corporate | Boston |
| Laki Triantafylidis | Latham & Watkins LLP | Associate | corporate | Not stated |
| Jennifer Boyd | Latham & Watkins LLP | Not stated | corporate | Not stated |
| Sue Kim | Latham & Watkins LLP | Not stated | corporate | Not stated |
| Cherrie Wang | Latham & Watkins LLP | Not stated | corporate | Not stated |
| Shayne Kennedy | Latham & Watkins LLP | Partner | capital markets | Orange County |
| Ross McAloon | Latham & Watkins LLP | Partner | capital markets | Bay Area |
| Jacob Walsh | Latham & Watkins LLP | Associate | capital markets | Not stated |
| Kennedy Holmes | Latham & Watkins LLP | Associate | capital markets | Not stated |
| Tony Noh | Latham & Watkins LLP | Associate | capital markets | Not stated |
| Eric Cho | Latham & Watkins LLP | Partner | tax | Los Angeles |
| Grace Jang | Latham & Watkins LLP | Associate | tax | Not stated |
| Holly Bauer | Latham & Watkins LLP | Partner | compensation and benefits | San Diego |
| Sara Schlau | Latham & Watkins LLP | Counsel | compensation and benefits | Orange County |
| Iryna Onyshchenko | Latham & Watkins LLP | Associate | compensation and benefits | Not stated |
| Nicole Liffrig Molife | Latham & Watkins LLP | Counsel | healthcare regulatory | Washington, D.C. |
| Megan Lich | Latham & Watkins LLP | Associate | healthcare regulatory | Not stated |
| Nathan Beaton | Latham & Watkins LLP | Partner | FDA | Washington, D.C. |
| Maya Frost-Belansky | Latham & Watkins LLP | Associate | FDA | Not stated |
| Trevor Thompson | Latham & Watkins LLP | Associate | FDA | Not stated |
| Robert Yeh | Latham & Watkins LLP | Counsel | intellectual property | San Diego |
| Kristina Funahashi | Latham & Watkins LLP | Associate | intellectual property | Not stated |
| Marissa Boynton | Latham & Watkins LLP | Partner | data privacy and cybersecurity | Washington, D.C. |
| Kathryn Parsons-Reponte | Latham & Watkins LLP | Associate | data privacy and cybersecurity | Not stated |
| Mandy Reeves | Latham & Watkins LLP | Partner | antitrust | Washington, D.C. |
| Patrick English | Latham & Watkins LLP | Partner | antitrust | Washington, D.C. |
| Nathaniel Amann | Latham & Watkins LLP | Associate | antitrust | Not stated |
| Eduard Grigoryan | Latham & Watkins LLP | Associate | emerging company and growth | Not stated |
| Emma Mayberry | Latham & Watkins LLP | Associate | emerging company and growth | Not stated |
26 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 533m (approximately US$533 million)
- What the figure measures
- Total transaction value
- Client
- Nalu Medical, Inc.Sell-side
- Counterparties
- Boston Scientific Corporation (Buy-side)